Seungwon Kim

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial”.

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

Cancer Cell(2024)10.1016/j.ccell.2024.10.007

N/A

1.3DataRank · unranked

59 citations

Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joë-Marc Chauvin, F. Amatore +48 more

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

Immunity(2020)10.1016/j.immuni.2019.11.014

N/A

0.979DataRank · unranked

684 citations

Cornelius Kürten, Tracy Tabib, Zengbiao Qi, Sayali Onkar, Ting Wang +11 more

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Nature Communications(2021)10.1038/s41467-021-23355-x

N/A

0.885DataRank · unranked

364 citations

Anthony R. Cillo, Tracy Tabib, Angen Liu, Sayali Onkar, Sheryl Kunning +15 more

Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing

Nature Communications(2021)10.1038/s41467-021-27619-4

N/A

0.858DataRank · unranked

303 citations

Aditi Kulkarni, Anthony R. Cillo, P.M.L. Santos, Anna K. Roble, Sayali Onkar +17 more

Neoadjuvant nivolumab alone or in combination with relatlimab or ipilimumab in resectable head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6018

N/A

0.695DataRank · unranked

17 citations

William E. Gooding, Simion I. Chiosea, Umamaheswar Duvvuri, Seungwon Kim, Mark Kubik +8 more

Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies

Cancer Cell(2025)10.1016/j.ccell.2025.02.026

N/A

0.621DataRank · unranked

62 citations

Dan P. Zandberg, Aditi Kulkarni, Simion I. Chiosea, Patricia M. Santos, Brian R. Isett +19 more

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Clinical Cancer Research(2014)10.1158/1078-0432.ccr-13-3360

N/A

0.598DataRank · unranked

53 citations

Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang +14 more

Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer

Oral Oncology(2025)10.1016/j.oraloncology.2025.107742

N/A

0.373DataRank · unranked

11 citations

Jie Chen, Carl Kim, Joshua D. Smith, Micah Harris, Krishna B. Singh +24 more

Divergent cancer etiologies drive distinct B cell signatures and tertiary lymphoid structures

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.29.123265

N/A

0.269DataRank · unranked

5 citations

Anthony R. Cillo, Tracy Tabib, Angen Liu, Sayali Onkar, Sheryl Kunning +12 more

Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6036

N/A

0.165DataRank · unranked

2 citations

Yael Flamand, Harry Quon, Gregory S. Weinstein, Ranee Mehra, Joaquín J. García +11 more

Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.24.660824

N/A

0.165DataRank · unranked

2 citations

Jie Chen, Carl Kim, Joshua D. Smith, Micah Harris, Krishna B. Singh +24 more

Phase II trial of adjuvant de-escalated radiation + adjuvant nivolumab for intermediate-high risk P16+ oropharynx cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6014

N/A

0.104DataRank · unranked

1 citations

Dan P. Zandberg, Adam Raben, Shaum Sridharan, Mark Kubik, José P. Zevallos +6 more

Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma

Research Square(2022)10.21203/rs.3.rs-2235839/v1

N/A

0.104DataRank · unranked

1 citations

Arivarasan Karunamurthy, Joë-Marc Chauvin, Robert M. Morrison, Yulong Bai, Jie Sun +40 more

683 CD8 T cell repertoire analysis of patients with resectable head and neck cancer enrolled in a phase II neoadjuvant study of α-PD1 administered alone or in combination with α-CTLA4 or α-LAG3

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0683

N/A

0DataRank · unranked

2 citations

Aditi Kulkarni, Housaiyin Li, Jie Chen, Lazar Vujanović, Seungwon Kim +4 more

Diagnostic Tonsillectomy and Surgical Margins After Completion Lateral Oropharyngectomy

JAMA Otolaryngology–Head & Neck Surgery(2026)10.1001/jamaoto.2026.0159

N/A

0DataRank · unranked

0 citations

Akshaya Raman, Shivam D. Patel, Joshua D. Smith, Steven B. Chinn, Seungwon Kim +6 more

The Nasoseptal Flap for Reconstruction of Lateral Oropharyngectomy Defects: A Clinical Series

The Laryngoscope(2021)10.1002/lary.29660

N/A

0DataRank · unranked

8 citations

Mathew Geltzeiler, Jad Ramadan, Jessica Moskovitz, Robert L. Ferris, Eric W. Wang +2 more

547 Reprogramming of type I interferon-responding tumor-reactive T lymphocytes associates with improved outcomes to neoadjuvant doublet immunotherapy in HNSCC

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0547

N/A

0DataRank · unranked

0 citations

P.M.L. Santos, Aditi Kulkarni, Brian R. Isett, Joy Marion, Simion I. Chiosea +8 more